Literature DB >> 3611357

Abnormal oxidant sensitivity and beta-chain structure of spectrin in hereditary spherocytosis associated with defective spectrin-protein 4.1 binding.

P S Becker, J S Morrow, S E Lux.   

Abstract

Hereditary spherocytosis (HS) is an inherited disorder of erythrocyte shape associated with spectrin deficiency and hemolytic anemia. In a subset of patients with the autosomal dominant form of HS, spectrin displays a reduced capacity to bind protein 4.1 and, therefore, actin; both functions that are critical to the membrane skeleton. A specific structural defect has not been identified in the spectrin from these patients. Chymotryptic digestion of the isolated spectrin chains shows impaired cleavage of the distal peptide of the beta subunit, the beta IV domain. In previous work, we have shown that mild oxidation markedly diminishes the binding capacity of normal spectrin for protein 4.1. Here we observe that chemical reduction of freshly isolated, untreated HS spectrin dramatically improves its function. Thus, a primary structural defect in the beta subunit of spectrin in this subtype of HS may lead to oxidant sensitivity, and secondarily, to a functional defect in the binding of spectrin to protein 4.1 and actin.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3611357      PMCID: PMC442269          DOI: 10.1172/JCI113104

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  64 in total

1.  Effects of sulfhydryl inhibition on red blood cells. II. Studies in vivo.

Authors:  H S JACOB; J H JANDL
Journal:  J Clin Invest       Date:  1962-07       Impact factor: 14.808

2.  Spectrin-actin associations studied by electron microscopy of shadowed preparations.

Authors:  C M Cohen; J M Tyler; D Branton
Journal:  Cell       Date:  1980-10       Impact factor: 41.582

3.  Band 4.1 causes spectrin-actin gels to become thixiotropic.

Authors:  C M Cohen; C Korsgren
Journal:  Biochem Biophys Res Commun       Date:  1980-12-31       Impact factor: 3.575

4.  A technique to detect reduced mechanical stability of red cell membranes: relevance to elliptocytic disorders.

Authors:  N Mohandas; M R Clark; B P Health; M Rossi; L C Wolfe; S E Lux; S B Shohet
Journal:  Blood       Date:  1982-04       Impact factor: 22.113

5.  Deficient red-cell spectrin in severe, recessively inherited spherocytosis.

Authors:  P Agre; E P Orringer; V Bennett
Journal:  N Engl J Med       Date:  1982-05-13       Impact factor: 91.245

6.  Spectrin domains: proteolytic susceptibility as a probe of protein structure.

Authors:  D W Speicher; V T Marchesi
Journal:  J Cell Biochem       Date:  1982       Impact factor: 4.429

7.  Identification of proteolytically resistant domains of human erythrocyte spectrin.

Authors:  D W Speicher; J S Morrow; W J Knowles; V T Marchesi
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

8.  Identification of functional domains of human erythrocyte spectrin.

Authors:  J S Morrow; D W Speicher; W J Knowles; C J Hsu; V T Marchesi
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

9.  Self-assembly of spectrin oligomers in vitro: a basis for a dynamic cytoskeleton.

Authors:  J S Morrow; V T Marchesi
Journal:  J Cell Biol       Date:  1981-02       Impact factor: 10.539

10.  Spectrin promotes the association of F-actin with the cytoplasmic surface of the human erythrocyte membrane.

Authors:  V M Fowler; E J Luna; W R Hargreaves; D L Taylor; D Branton
Journal:  J Cell Biol       Date:  1981-02       Impact factor: 10.539

View more
  9 in total

1.  Sp alpha V/41: a common spectrin polymorphism at the alpha IV-alpha V domain junction. Relevance to the expression level of hereditary elliptocytosis due to alpha-spectrin variants located in trans.

Authors:  N Alloisio; L Morlé; J Maréchal; A F Roux; M T Ducluzeau; D Guetarni; B Pothier; F Baklouti; A Ghanem; R Kastally; J Delaunay
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

Review 2.  Current problems in haematology. 2: Hereditary spherocytosis.

Authors:  J C Smedley; A J Bellingham
Journal:  J Clin Pathol       Date:  1991-06       Impact factor: 3.411

3.  Two distinct variants of erythrocyte spectrin beta IV domain.

Authors:  B Pothier; N Alloisio; L Morlé; J Maréchal; H Barthélemy; M T Ducluzeau; A Dorier; J Delaunay
Journal:  Hum Genet       Date:  1989-11       Impact factor: 4.132

Review 4.  The Spectrinome: The Interactome of a Scaffold Protein Creating Nuclear and Cytoplasmic Connectivity and Function.

Authors:  Steven R Goodman; Daniel Johnson; Steven L Youngentob; David Kakhniashvili
Journal:  Exp Biol Med (Maywood)       Date:  2019-09-04

5.  Beta spectrin kissimmee: a spectrin variant associated with autosomal dominant hereditary spherocytosis and defective binding to protein 4.1.

Authors:  P S Becker; W T Tse; S E Lux; B G Forget
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

6.  Combined ankyrin and spectrin deficiency in hereditary spherocytosis.

Authors:  A Pekrun; S W Eber; A Kuhlmey; W Schröter
Journal:  Ann Hematol       Date:  1993-08       Impact factor: 3.673

7.  The murine mutation jaundiced is caused by replacement of an arginine with a stop codon in the mRNA encoding the ninth repeat of beta-spectrin.

Authors:  M L Bloom; T M Kaysser; C S Birkenmeier; J E Barker
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

8.  Decreased membrane mechanical stability and in vivo loss of surface area reflect spectrin deficiencies in hereditary spherocytosis.

Authors:  J A Chasis; P Agre; N Mohandas
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

9.  Proper cytoskeletal architecture beneath the plasma membrane of red blood cells requires Ttll4.

Authors:  Faryal Ijaz; Yasue Hatanaka; Takahiro Hatanaka; Koji Tsutsumi; Takayuki Iwaki; Kazuo Umemura; Koji Ikegami; Mitsutoshi Setou
Journal:  Mol Biol Cell       Date:  2016-12-14       Impact factor: 4.138

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.